• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯妥英注射或输注后的血浆浓度(作者译)

[Plasma concentrations after injection or infusion of phenytoin (author's transl)].

作者信息

Schmidt D, Vogel A

出版信息

Klin Wochenschr. 1977 Mar 1;55(5):219-23. doi: 10.1007/BF01487714.

DOI:10.1007/BF01487714
PMID:846182
Abstract

Intravenous injection of 3 mg/kg phenytoin produced plasma concentrations of 4.2 mug/ml in five volunteers, which were below the concentration of 10-20 mjg/ml necessary for effective antiarrhythmic and antiepileptic treatment. Intravenous injection of 250 mg phenytoin followed by infusion of 750 mg phenytoin in a mean dosage of 1.7 mg/kg x h in nine patients with epilepsy produced plasma concentrations of 10.2 resp. 15.1 mug/ml after 4 resp. 8h. An oral maintenance therapy of 5-6 mg/kg is suggested. Therapeutic plasma concentrations were rapidly reached with this regimen.

摘要

静脉注射3毫克/千克苯妥英钠后,五名志愿者的血浆浓度为4.2微克/毫升,低于有效抗心律失常和抗癫痫治疗所需的10 - 20微克/毫升的浓度。对九名癫痫患者静脉注射250毫克苯妥英钠,随后以平均剂量1.7毫克/千克×小时输注750毫克苯妥英钠,4小时和8小时后的血浆浓度分别为10.2微克/毫升和15.1微克/毫升。建议口服维持治疗剂量为5 - 6毫克/千克。采用该治疗方案可迅速达到治疗性血浆浓度。

相似文献

1
[Plasma concentrations after injection or infusion of phenytoin (author's transl)].苯妥英注射或输注后的血浆浓度(作者译)
Klin Wochenschr. 1977 Mar 1;55(5):219-23. doi: 10.1007/BF01487714.
2
Rapid infusion of phenytoin sodium loading doses.
Am J Hosp Pharm. 1981 Mar;38(3):354-7.
3
[Infusion of phenytoin concentrate in a child (author's transl)].[儿童苯妥英浓缩液的输注(作者译)]
Dtsch Med Wochenschr. 1975 May 2;100(18):1012-6. doi: 10.1055/s-0028-1106328.
4
[Use and results of treatment with phenytoin infusion concentrate (author's transl)].苯妥英输注浓缩液的使用及治疗结果(作者译)
Dtsch Med Wochenschr. 1974 Oct 4;99(40):1961-4. doi: 10.1055/s-0028-1108075.
5
[Haemodynamic reactions to injection and subsequent infusion of phenytoin (author's transl)].苯妥英钠注射及后续输注的血液动力学反应(作者译)
Dtsch Med Wochenschr. 1974 Nov 8;99(45):2279-83. doi: 10.1055/s-0028-1108125.
6
Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmias.
Eur J Clin Pharmacol. 1977;11(1):1-6. doi: 10.1007/BF00561779.
7
[Serum level determination in patients with acute myocardial infarction under diphenylhydantoin therapy].[苯妥英钠治疗下急性心肌梗死患者的血清水平测定]
Z Gesamte Inn Med. 1979 Oct 15;34(20):suppl 282-4.
8
[(Author's transl) Indications for phenytoin in cardiac arrhythmias].(作者译)苯妥英钠在心律失常中的应用指征
Dtsch Med Wochenschr. 1974 Mar 29;99(13):638-42. doi: 10.1055/s-0028-1107816.
9
Evaluation of a proposed method for phenytoin maintenance dose prediction following an intravenous loading dose.
Eur J Clin Pharmacol. 1987;32(2):141-8. doi: 10.1007/BF00542186.
10
[Procain amide and phenytoin as anti-arrhythmia agents, some dosage principles].
Tidsskr Nor Laegeforen. 1974 Jun 30;94(18):1198-200.

引用本文的文献

1
The new anticonvulsant drugs. Implications for avoidance of adverse effects.新型抗惊厥药物。避免不良反应的意义。
Drug Saf. 1994 Dec;11(6):422-31. doi: 10.2165/00002018-199411060-00004.
2
Serum anticonvulsant concentrations and the risk of drug induced skin eruptions.血清抗惊厥药物浓度与药物性皮肤疹风险
J Neurol Neurosurg Psychiatry. 1984 Jun;47(6):642-4. doi: 10.1136/jnnp.47.6.642.

本文引用的文献

1
Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients.不同稳态血清苯妥英浓度下癫痫患者示踪剂量苯妥英消除率。
Br J Clin Pharmacol. 1974 Apr;1(2):155-61. doi: 10.1111/j.1365-2125.1974.tb00225.x.
2
5, 5-Diphenylhydantoin (dilantin) blood levels after oral or intravenous dosage in man.人体口服或静脉注射剂量后5,5-二苯基乙内酰脲(苯妥英)的血药浓度。
Acta Pharmacol Toxicol (Copenh). 1960;16:331-46. doi: 10.1111/j.1600-0773.1960.tb01218.x.
3
Diphenylhydantoin (dilantin) sodium used parenterally in control of convulsions; a five-year report.
J Am Med Assoc. 1956 Feb 4;160(5):385-8. doi: 10.1001/jama.1956.02960400043010.
4
Fatalities following intravenous use of sodium diphenylhydantoin for cardiac arrhythmias. Report of two cases.静脉注射苯妥英钠治疗心律失常后的死亡病例。两例报告。
JAMA. 1967 Apr 24;200(4):335-6.
5
Intramuscular administration of phenytoin.苯妥英钠的肌肉注射
Neurology. 1966 Mar;16(3):288-92. doi: 10.1212/wnl.16.3.288.
6
Blood levels of drug at the equilibrium state after multiple dosing.多次给药后达到平衡状态时药物的血药浓度。
Nature. 1965 Sep 18;207(5003):1301-2. doi: 10.1038/2071301a0.
7
Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.静脉注射后苯妥英在正常人体中的代谢情况。
Clin Pharmacol Ther. 1969 Jul-Aug;10(4):498-504. doi: 10.1002/cpt1969104498.
8
[The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)].[蓄积与消除对苯妥英钠(二苯乙内酰脲)测定的意义]
Dtsch Med Wochenschr. 1969 Jun 13;94(24):1265-72. doi: 10.1055/s-0028-1111205.
9
Fatal results from diphenylhydantoin administered intravenously.静脉注射苯妥英钠导致的致命后果。
JAMA. 1968 Nov 25;206(9):2118-9. doi: 10.1001/jama.1968.03150090194036.
10
Comparison of blood levels with oral and intramuscular diphenylhydantoin.口服和肌肉注射苯妥英钠后的血药浓度比较。
Neurology. 1968 Aug;18(8):782-4. doi: 10.1212/wnl.18.8.782.